FDA Extends Comment Period on Proposed IRB, Informed Consent Rules
December 1, 2022
In response to requests for more time to weigh in on a pair of long-awaited proposed rules on IRB review and informed consent requirements, the FDA has extended the comment period to Dec. 28.
